(Q44547466)

4 December 2017

title

Comparison of vasodilatory prostaglandins with respect to cAMP-mediated phosphorylation of a target substrate in intact human platelets (English)

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

5 November 2022

1 reference

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

5 November 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

5 November 2022

author name string

C. Nolte

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1713458

5 November 2022

M. Eigenthaler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1713458

5 November 2022

P. Schanzenbächer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1713458

5 November 2022

U. Walter

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1713458

5 November 2022

language of work or name

English

0 references

publication date

1 July 1991

1 reference

4 December 2017

5 July 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1713458

full work available at URL

5 November 2022

https://api.elsevier.com/content/article/PII:000629529190711D?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

https://api.elsevier.com/content/article/PII:000629529190711D?httpAccept=text/plain

5 November 2022

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

5 November 2022

published in

Biochemical Pharmacology

1 reference

4 December 2017

volume

42

1 reference

4 December 2017

issue

2

1 reference

4 December 2017

page(s)

253-262

1 reference

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

4 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

Clinical implications of prostaglandin and thromboxane A2 formation (1).

5 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

Clinical implications of prostaglandin and thromboxane A2 formation (2).

5 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

Prostaglandin E1 and arterial occlusive disease: pharmacological considerations

5 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

Intracoronary prostaglandin E1 plus streptokinase in acute myocardial infarction

5 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

Iloprost inhibits neutrophil function in vitro and in vivo and limits experimental infarct size in canine heart

5 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

Randomized trial of prostacyclin infusion in acute myocardial infarction

5 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

Hemodynamic and angiographic effects of prostaglandin E1 in coronary artery disease

5 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

Platelets and antiplatelet therapy in ischemic heart disease

5 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

Intracellular mechanism of action of vasodilators

5 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

Vasodilator-stimulated protein phosphorylation in platelets is mediated by cAMP- and cGMP-dependent protein kinases

5 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

Purification of a vasodilator-regulated phosphoprotein from human platelets

5 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria

5 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

Biosynthesis of von Willebrand protein by human endothelial cells: processing steps and their intracellular localization

5 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein

5 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function

5 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

Platelet and vessel associated prostacyclin and thromboxane A2/prostaglandin endoperoxide receptors

5 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

Desensitization of platelets to iloprost. Loss of specific binding sites and heterologous desensitization of adenylate cyclase

5 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

Separate receptors for prostacyclin and prostaglandin E2 on human gel-filtered platelets

5 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

Cytotoxic enzyme release and oxygen centered radical formation in human neutrophils are selectively inhibited by E-type prostaglandins but not by PGI2

5 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

Redirection of prostaglandin endoperoxide metabolism at the platelet-vascular interface in man

5 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

Pulmonary extraction and pharmacokinetics of prostaglandin E1 during continuous intravenous infusion in patients with adult respiratory distress syndrome.

5 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

Pharmacokinetics and pharmacodynamics of the prostacyclin analogue iloprost in man.

5 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

Antiplatelet effects of intravenous iloprost in patients with peripheral arterial obliterative disease. A placebo-controlled dose-response study

5 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

The interaction of sodium nitroprusside with human endothelial cells and platelets: nitroprusside and prostacyclin synergistically inhibit platelet function

5 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

Interactions of iloprost and sodium nitroprusside on vascular smooth muscle and platelet aggregation

5 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

Selective anti-platelet aggregation synergism between a prostacyclin-mimetic, RS93427 and the nitrodilators sodium nitroprusside and glyceryl trinitrate

5 November 2022

37

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

Are there markers of the blood-vessel wall interaction and of thrombus formation that can be used clinically?

5 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/0006-2952(91)90711-D

5 November 2022

Identifiers

1 reference

4 December 2017

1 reference